Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome

Sleep Medicine

Volumn 16, Issue 11, 2015, Pages 1342-1347

  Schneider, Juliane ^a   Krafft, Alexander ^b   Manconi, Mauro ^c   Hübner, Astrid ^a   Baumann, Christian ^a   Werth, Esther ^a   Gyr, Thomas ^c   Bassetti, Claudio ^c,d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Ospedale Civico Lugano   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Actigraphy; Anemia; Ferric carboxymaltose; Pregnancy; Restless legs syndrome

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; FERRIC ION; MALTOSE;

ACTIMETRY; ADULT; ALLERGIC REACTION; ANEMIA; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EXPLORATORY RESEARCH; FEMALE; FERRITIN BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION; INJECTION SITE EXTRAVASATION; INJECTION SITE REACTION; IRON DEFICIENCY; MULTICENTER STUDY; OPEN STUDY; PERIODIC LIMB MOVEMENT DISORDER; PILOT STUDY; PITTSBURGH SLEEP QUALITY INDEX; PREGNANT WOMAN; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; SLEEP QUALITY; THIRD TRIMESTER PREGNANCY; VIRAL GASTROENTERITIS; ANALOGS AND DERIVATIVES; ANEMIA, IRON-DEFICIENCY; BLOOD; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDY; SWITZERLAND; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; ANEMIA, IRON-DEFICIENCY; DOUBLE-BLIND METHOD; FEMALE; FERRIC COMPOUNDS; FERRITINS; HUMANS; MALTOSE; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RESTLESS LEGS SYNDROME; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 84944546501     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2015.08.006     Document Type: Article

References (37)

1. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995, 10(5):634-642.
2. Allen R.P., Picchietti D., Hening W.A., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4(2):101-119.
3. Montplaisir J., Boucher S., Poirier G., et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997, 12(1):61-65.
4. Ka E. Restless legs: a clinical study. Acta Med Scand 1945, 158(Suppl.):1-124.
5. Manconi M., Govoni V., De Vito A., et al. Restless legs syndrome and pregnancy. Neurology 2004, 63(6):1065-1069.
6. Neau J.P., Marion P., Mathis S., et al. Restless legs syndrome and pregnancy: follow-up of pregnant women before and after delivery. Eur Neurol 2010, 64(6):361-366.
7. Manconi M., Ulfberg J., Berger K., et al. When gender matters: restless legs syndrome. Report of the "RLS and woman" workshop endorsed by the European RLS Study Group. Sleep Med Rev 2012, 16(4):297-307.
8. Hubner A., Krafft A., Gadient S., et al. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology 2013, 80(8):738-742.
9. Alves D.A., Carvalho L.B., Morais J.F., et al. Restless legs syndrome during pregnancy in Brazilian women. Sleep Med 2010, 11(10):1049-1054.
10. Pavord S., Myers B., Robinson S., et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2012, 156(5):588-600.
11. Malek A. In vitro studies of ferric carboxymaltose on placental permeability using the dual perfusion model of human placenta. Arzneimittelforschung 2010, 60(6a):354-361.
12. Garcia-Borreguero D., Ferini-Strambi L., Kohnen R., et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 2012, 19(11):1385-1396.
13. Koo J., Zavras A. Antiepileptic drugs (AEDs) during pregnancy and risk of congenital jaw and oral malformation. Oral Dis 2013, 19(7):712-720.
14. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003, 4(3):310-317.
15. Froessler B., Collingwood J., Hodyl N.A., et al. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth 2014, 14:115.
16. Trenkwalder C. Emergency call from gynecologists: how to treat restless legs syndrome during pregnancy?. Eur J Neurol 2013, 20(9):1223-1224.
17. Wang J., O'Reilly B., Venkataraman R., et al. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med 2009, 10(9):973-975.
18. Trotti L.M., Bhadriraju S., Becker L.A. Iron for restless legs syndrome. Cochrane Database Syst Rev 2012, (5). CD007834.
19. Davis B.J., Rajput A., Rajput M.L., et al. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 2000, 43(2):70-75.
20. Ondo W.G. Intravenous iron dextran for severe refractory restless legs syndrome. Sleep Med 2010, 11(5):494-496.
21. Picchietti D.L., Wang V.C., Picchietti M.A. Intravenous iron given prior to pregnancy for restless legs syndrome is associated with remission of symptoms. J Clin Sleep Med 2012, 8(5):585-586.
22. Vadasz D., Ries V., Oertel W.H. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin. Sleep Med 2013, 14(11):1214-1216.
23. Walters A.S., LeBrocq C., Dhar A., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4(2):121-132.
24. Valko P.O., Bassetti C.L., Bloch K.E., et al. Validation of the fatigue severity scale in a Swiss cohort. Sleep 2008, 31(11):1601-1607.
25. Johns M.W. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994, 17(8):703-710.
26. Buysse D.J., Reynolds C.F., Monk T.H., et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(2):193-213.
27. King M.A., Jaffre M.O., Morrish E., et al. The validation of a new actigraphy system for the measurement of periodic leg movements in sleep. Sleep Med 2005, 6(6):507-513.
28. Inoue Y., Kuroda K., Hirata K., et al. Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial. Neuropsychobiology 2011, 63(1):35-42.
29. Oertel W.H., Benes H., Garcia-Borreguero D., et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med 2008, 9(3):228-239.
30. Earley C.J., Heckler D., Allen R.P. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 2004, 5(3):231-235.
31. Earley C.J., Heckler D., Allen R.P. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med 2005, 6(4):301-305.
32. Allen R.P., Adler C.H., Du W., et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Med 2011, 12(9):906-913.
33. Brise H., Hallberg L. Absorbability of different iron compounds. Acta Med Scand Suppl 1962, 376:23-37.
34. Earley C.J., Horska A., Mohamed M.A., et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10(2):206-211.
35. Allen R.P., Earley C.J. The role of iron in restless legs syndrome. Mov Disord 2007, 22(Suppl. 18):S440-8.
36. Srivanitchapoom P., Pandey S., Hallett M. Restless legs syndrome and pregnancy: a review. Parkinsonism & related disorders 2014, 20(7):716-722.
37. Dzaja A., Wehrle R., Lancel M., et al. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep 2009, 32(2):169-174.